Amplification of chromosome 1q is associated with poorer treatment outcomes for patients with relapsed/refractory and newly diagnosed multiple myeloma.
The Myeloma Institute, located within the Winthrop P. Rockefeller Cancer Institute at UAMS (UAMS)
The Paula and Rodger Riney Foundation have given $1.8 million to the University of Arkansas for Medical Sciences Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research.
Rodger Riney is the founder and former CEO of the discount brokerage firm Scottrade of St. Louis. He was diagnosed with multiple myeloma in 2015 and has since become an advocate for research and treatment of the disease, including serving on the board of directors for the Multiple Myeloma Research Foundation, UAMS said in a news release.